{
 "generic_name": "Epinephrine Bitartrate, Lidocaine Hydrochloride Injection",
 "slug": "epinephrine-bitartrate-lidocaine-hydrochloride-injection",
 "brand_names": [
  "Xylocaine",
  "Xylocaine Mpf"
 ],
 "fda_status": [
  "Current"
 ],
 "last_fda_update": "09/22/2026",
 "first_posted": "02/22/2012",
 "synced_at": "2026-10-01T04:04:04.751Z",
 "presentations": [
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3177-01",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 250 mg/50 mL (0.5%; 1:200,000) (NDC 0409-3177-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery and Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-1209-01",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 75 mg/5 mL (1.5%; 1:200,000) (NDC 0409-1209-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: November 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3182-01",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:100,000) (NDC 0409-3182-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery and Estimated Recovery: December 2028; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3178-01",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 200 mg/20 mL (1%; 1:100,000) (NDC 0409-3178-01)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: October 2026; Estimated Recovery: December 2026; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3178-02",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 300 mg/30 mL (1%; 1:100,000) (NDC 0409-3178-02)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next Delivery: November 2026; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3182-02",
   "presentation": "Lidocaine Hydrochloride and Epinephrine, Injection, 600 mg/30 mL (2%; 1:100,000) (NDC 0409-3182-02)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3182-03",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 1 g/50 mL (2%; 1:100,000) (NDC 0409-3182-03)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3178-03",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 500 mg/50 mL (1%; 1:100,000) (NDC 0409-3178-03)",
   "availability": "Limited",
   "availability_raw": "Limited Availability",
   "fda_note": "Limited Supply Available. Next Delivery: May 2027; Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay"
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3181-01",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 450 mg/30 mL (1.5%; 1:200,000) (NDC 0409-3181-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Hospira, Inc., a Pfizer Company",
   "package_ndc": "0409-3183-01",
   "presentation": "Lidocaine Hydrochloride And Epinephrine, Injection, 400 mg/20 mL (2%; 1:200,000) (NDC 0409-3183-01)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": null
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-487-17",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-487-37",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-488-17",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-17)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-488-37",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 15 mg/1 mL (NDC 63323-488-37)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-489-27",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-27)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-489-17",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 20 mg/1 mL (NDC 63323-489-17)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-481-57",
   "presentation": "Xylocaine, Injection, .005 mg/1 mL; 5 mg/1 mL (NDC 63323-481-57)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-482-57",
   "presentation": "Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-57)",
   "availability": "Unavailable",
   "availability_raw": "Unavailable",
   "fda_note": "Next release September 2026. Check wholesalers for inventory."
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-482-27",
   "presentation": "Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-27)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-482-17",
   "presentation": "Xylocaine, Injection, .01 mg/1 mL; 10 mg/1 mL (NDC 63323-482-17)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-483-57",
   "presentation": "Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-57)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  },
  {
   "company": "Fresenius Kabi USA, LLC",
   "package_ndc": "63323-483-27",
   "presentation": "Xylocaine, Injection, .01 mg/1 mL; 20 mg/1 mL (NDC 63323-483-27)",
   "availability": "Available",
   "availability_raw": "Available",
   "fda_note": "Check wholesalers for inventory"
  }
 ],
 "changes": []
}